Stockholders' Deficit - Schedule of Warrants Activity (Details) - Warrants [Member] |
9 Months Ended |
|---|---|
|
Sep. 30, 2020
$ / shares
shares
| |
| Number of warrants, Outstanding, Beginning balance | shares | 63,458,546 |
| Number of warrants, Increase during the period as a result of down round provisions | shares | 271,987,673 |
| Number of warrants, Warrants expired | shares | (1) |
| Number of warrants, Outstanding, Ending balance | shares | 335,446,218 |
| Weighted average exercise price, Warrants outstanding, Beginning balance | $ / shares | $ 1.44 |
| Weighted average exercise price, Warrants Increase during the period as a result of down round provisions | $ / shares | |
| Weighted average exercise price, Warrants expired | $ / shares | (3,150.00) |
| Weighted average exercise price, Warrants outstanding, Ending balance | $ / shares | $ 0.27 |
| X | ||||||||||
- Definition Weighted average exercise price, warrants outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock warrants of the plan that expired. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, Warrants Increase during the period as a result of down round provisions. No definition available.
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Increase (decrease) in the number of shares under non-option equity instrument agreements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|